Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002050762 | SCV002111713 | likely benign | not provided | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004988787 | SCV005613650 | uncertain significance | Inborn genetic diseases | 2024-11-10 | criteria provided, single submitter | clinical testing | The c.446A>G (p.D149G) alteration is located in exon 4 (coding exon 4) of the KMT2C gene. This alteration results from a A to G substitution at nucleotide position 446, causing the aspartic acid (D) at amino acid position 149 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |